Book a consultation at our Rego Park location to discuss your specific concerns and get a personalized plan that actually makes sense for your body
Freezing can denature the peptide and reduce potency
In the UK, NICE guidance (NG28) recommends GLP-1 receptor agonists for specific patient populations with type 2 diabetes, typically after inadequate control on oral agents and according to specific criteria
Beyond the conventional risk factors linked to CVD, patients with CKD often have a variety of extra risk factors, such as electrolyte imbalances, proteinuria, inflammation, elevated oxidative stress, and changed NO levels (Uhlig et al
If a GLP-1 agonist is, in fact, the best option for a patient, they can comparison shop